We are live on ! Find out more
ERNA icon

Eterna Therapeutics

32 hedge funds and large institutions have $78.3M invested in Eterna Therapeutics in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

14,007% more capital invested

Capital invested by funds: $555K → $78.3M (+$77.7M)

625% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 4

357% more funds holding

Funds holding: 732 (+25)

0% more ownership

Funds ownership: 0%0% (+0%)

57% less call options, than puts

Call options by funds: $3.96M | Put options by funds: $9.29M

Holders
32
Holders Change
+25
Holders Change %
+357.14%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
2
Reduced
Closed
4
Calls
$3.96M
Puts
$9.29M
Net Calls
-$5.32M
Net Calls Change
-$5.32M

ERNA Hedge Fund Activity: Q2 2021 in Review

32 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2021, worth a combined $78.3M — up 14,007% from $555K a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ERNA positions and 4 closed out — a net gain of 25 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $26.9M. The largest seller was Citadel Advisors, exiting entirely with an estimated $432K sold.

  • 32 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2021, up from 7 in Q1 2021.
  • Funds reported $78.3M of Eterna Therapeutics stock for Q2 2021, up 14,007% quarter-over-quarter.
  • 29 funds opened new Eterna Therapeutics positions in Q2 2021 and 4 closed out, a net change of +25 holders.
  • The largest Eterna Therapeutics buyer in Q2 2021 was BlackRock, an estimated $26.9M added.
  • The largest Eterna Therapeutics seller in Q2 2021 was Citadel Advisors, an estimated $432K sold.

Based on aggregated 13F filings for Q2 2021.